Supplements And Nutrition Packaging Market Key Players, Industry Share, Growth, And Forecast To 2030: Grand View Research Inc.

 Supplements And Nutrition Packaging Market Growth & Trends

The global supplements and nutrition packaging market size is expected to surpass USD 40.54 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.2% from 2024 to 2030. The rising demand for immunity-boosting supplements due to the COVID-19 outbreak, ease in access to supplements, increasing disposable income, and consumer awareness regarding nutrition, health, and wellness. However, the presence of counterfeit products is hampering the market of supplements which in turn decline the demand for packaging.

The COVID-19 pandemic started in December 2019 in Wuhan, China, and it subsequently spread at global levels. It led to 4 million deaths as of June 2020. People with low immunity, especially, the geriatric demography, along with others suffering from medical conditions such as diabetes, heart disease, asthma, and cancer are highly vulnerable to complications arising due to the COVID-19 infection. Thus, consumers are increasingly consuming supplements rich in omega-3 and omega-6 fatty acids Vitamin D, Zinc, and vitamin C to boost their immunity levels. This has further resulted in a surge in demand for such supplements, which, in turn, is benefitting the manufacturers of supplements and nutrition packaging.

Further, the accessibility of dietary and nutritional supplements is increasing due to the emergence of e-commerce. Although it is difficult to buy dietary and nutrition supplements online due to a lack of product knowledge and suitability concerns, sales of these products have continued to increase. Some of the key players in this market are striving hard to educate consumers, in order to improve the online shopping experience. Thus, accessibility to these products is increasing through online retail. Thus, driving the demand for packaging.

According to the data published by The Italian Medicines Agency, over the past 5 years, 27 known counterfeit medicines cases were reported in the legitimate supply chain, whereas 170 cases were reported in the illegitimate supply chain among the EU member states. In Europe, drug ingredients used in dietary supplements are a major concern. The European Directorate for the Quality of Medicines lab networks tested 370 dietary supplements that were labeled as herbal products, but nearly 47% contained non-declared active pharmaceutical ingredients. These factors are expected to negatively impact market growth. The lack of sufficient regulations for product approvals is another key factor restricting the demand for packaging.

Request a free sample copy or view report summary: Supplements And Nutrition Packaging Market Report

Supplements And Nutrition Packaging Market Report Highlights

• In terms of revenue, the secondary & tertiary packaging type is projected to ascend at the highest CAGR of 5.2% over the forecast period. The secondary & tertiary packaging protect the primary packaging and assists in smooth and damage-free transportation of the products throughout the supply chain. The expanding e-commerce business is driving demand for secondary & tertiary packaging
• Plastic segment accounted for the largest revenue share of 77.4% in 2022. Various plastic resins, including HDPE, PET, and PP, are commonly used to make packaging bottles, jars, sachets, pouches, and blister packs for supplements. Properties such as lightness, chemical inertness, and ease of molding along with low cost and wide availability of plastic materials are the key factors contributing to their high adoption for the manufacturing of supplements & nutrition packaging products
• Supplements & nutrition packaging in Asia Pacific was valued at USD 11.46 million in 2022 and is expected to grow at a CAGR of 4.8% over the forecast period. The presence of highly populated countries, such as China and India, with growing urbanization and spending power of the population, is attributed to driving the market in the region
• The global supplements and nutrition packaging market is moderately fragmented, with the presence of a large number of small-sized and medium-sized companies. The market participants are primarily offering rigid packaging solutions, such as plastic and glass bottles, as well as flexible packagingsolutions such as stand-up pouches, sachets, and others

Access Press Release@ https://www.grandviewresearch.com/press-release/global-supplements-nutrition-packaging-market

Supplements And Nutrition Packaging Segmentation

Grand View Research has segmented the global supplements and nutrition packaging market report based on packaging type, material, formulation and region:

Supplements And Nutrition Packaging Material Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

• Plastic
  • PET
  • HDPE
  • PP
  • Others
• Paper & Paperboard
• Glass
• Metals

Supplements And Nutrition Packaging Product Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

• Bottles & Jars
• Tins & Cans
• Pouches
• Sachets
• Blisters
• Other Products

Supplements And Nutrition Packaging Formulation Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

• Tablets
• Capsules & Pills
• Powder
• Soft Gel
• Liquid

Supplements And Nutrition Packaging Regional Outlook (Volume, Million Units; Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players in the Supplements And Nutrition Packaging Market

• Glenroy, Inc.
• Alpha Packaging
• Comar, LLC
• Graham Packaging Company
• Gerresheimer AG
• ePac Holdings, LLC
• Law Print & Packaging Management Ltd.
• MPS (Molded Packaging Solutions)
• OPM Labels
• Container and Packaging Supply, Inc.
• PRETIUM PACKAGING
• Eagle Flexible Packaging
• TRL Packaging
• Uniflex
• Altium Packaging

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nuclear Magnetic Resonance Spectroscopy Market to Witness Exponential Growth by 2030: Grand View Research Inc.

 Nuclear Magnetic Resonance Spectroscopy Market Growth & Trends

The global nuclear magnetic resonance spectroscopy market size is expected to reach USD 1.08 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to expand at a CAGR of 5.1% from 2024 to 2030. The rising need for metabolomics-based diagnosis, coupled with increasing usage in various fields, is anticipated to surge the growth of the market. Bruker offers nuclear magnetic resonance (NMR) spectroscopy solutions for multi-omics, tissue SpatialOMx, proteomics, functional structural biology, biomolecular condensates, and biopharma and applied.

The market for NMR spectroscopy witnessed incremental growth in 2021 and is anticipated to showcase a similar trend in the forecast period. The instrument demand from academic and university research centers is a significant contributor to the revenue. For instance, in June 2021, National Science Foundation announced an investment of USD 40 million to develop the Network for Advanced NMR (NAN) between the University of Georgia, UConn School of Medicine, and UW–Madison’s National Magnetic Resonance Facility at Madison.

Other determinants such as the rapidly expanding demand for generic medicine, technical improvements in healthcare, as well as government initiatives and grants in the nuclear magnetic resonance spectroscopy industry are also contributing to the market's growth. In the U.S., government-funded - S10 Instrumentation Programs have been formed to support the purchase of instruments, including NMR spectroscopy. There are three active funding programs with June 2023 as the deadline. These programs range from USD 25,000 to USD 2,000,000.

The COVID-19 pandemic is anticipated to positively impact the demand for the product. However, supply shortages and accelerated prices of raw materials impacted the profitability of the players. The prices of key raw materials such as copper, steel, and metallic, used for superconductors, have risen over the last decade.

The increasing demand for cancer diagnostics is expected to majorly drive market growth in the coming years. Diagnosis for Parkinson’s disease, cancer, infectious diseases, and psychiatric disorders, has been investigated with the use of NMR spectroscopy. For instance, in January 2022, a study was conducted at the University of Oxford to develop a new blood test, through NMR metabolomics, that can identify a range of cancers.

On the other hand, this is a niche market with limited players. Additionally, NMR spectroscopy is considered to be bulky and expensive, as its cost ranges from around a few hundred thousand dollars for 400 MHz, to millions for higher field magnets. Additionally, the requirement of high-field magnets, filled with cryogenic fluids regularly, and routine maintenance of electronics and probes increases the cost. 

Request a free sample copy or view report summary: Nuclear Magnetic Resonance Spectroscopy Market Report

Nuclear Magnetic Resonance Spectroscopy Market Report Highlights 

• By product, the instruments segment held the dominant share of the NMR spectroscopy industry, owing to the increasing demand by universities and research centers for high-field NMR spectroscopy
• The steadily increasing scope of the product has a significant impact on the market. For instance, solid-state NMR spectroscopy (SSNMR) is considered an analytical tool for drug characterization, hence propelling the market growth
• By type, the high-field NMR spectroscopy segment dominated the market in 2023, since it offers better sensitivity to the researchers
• By end-use, the academic segment held a larger share in 2023; numerous universities employ NMR analysis to enhance chemical identification in pharmaceutical and chemical industries
• North America held a substantial share in the global market in 2023 due to the presence of a large number of universities and increasing funding support by the government to enhance research infrastructure
• The Asia Pacific region is projected to grow considerably in the future, owing to the rising availability of raw materials and increasing biomedical research in the pharma and biotech industry

Access Press Release@ https://www.grandviewresearch.com/press-release/global-nuclear-magnetic-resonance-spectroscopy-market

Nuclear Magnetic Resonance Spectroscopy Market Segmentation

Grand View Research has segmented the global nuclear magnetic resonance spectroscopy market report based on product, type, end-use and region:

Nuclear Magnetic Resonance Spectroscopy Product Outlook (Revenue, USD Million, 2018 - 2030­)

• Instruments
• Consumables

Nuclear Magnetic Resonance Spectroscopy Type Outlook (Revenue, USD Million, 2018 - 2030)

• Low-field NMR Spectroscopy
• High-field NMR Spectroscopy

Nuclear Magnetic Resonance Spectroscopy End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Academic
• Pharmaceutical and Biotech Companies
• Agriculture and Food
• Chemical Industry
• Others

Nuclear Magnetic Resonance Spectroscopy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Singapore
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in the Nuclear Magnetic Resonance Spectroscopy Market

• JEOL Ltd.
• Thermo Fisher Scientific Inc.
• Bruker
• Magritek
• Oxford Instruments
• Nanalysis Corp.
• Anasazi Instruments, Inc.
• QoneTec
• Advanced Magnetic Resonance Limited

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Microprocessor Market Revenue is Expected to Reach $196.50 Billion by 2030: Grand View Research Inc.

 Microprocessor Market Growth & Trends

The global microprocessor market size is projected to reach USD 196.50 billion by 2030, growing at a CAGR of 8.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Moreover, the global microprocessor market volume is projected to reach 3.90 billion units in 2030. In recent years, growing IT industries and increasing data centers have been observed continuously demanding cloud and web-based services. The shifting inclination towards cloud data storage is expected to result in growing demand for servers, further boosting the demand for microprocessors over the forecast years. Besides, there is a surging need to minimize the size of microprocessors due to the compact size of devices that enable improved processing, speed, and portability, resulting in the growth of the market across the globe.

Escalating demand for microprocessors in various applications such as 5G technology, smart cards, artificial intelligence (AI), and machine learning techniques is expected to be one of the key factors boosting the market growth. The aforementioned applications enable speedier transit of organizational data across the IT network and thus find extensive usage in public clouds, data center facilities, and connected devices. Most organizations are, therefore, incorporating ICs to support the functioning of advanced technologies in devices, resulting in lower operational costs.

Embedded devices application is driven by extensive usage of microprocessors. Based on the type of application, embedded microprocessors can use 8, 16, 32, and 64-bit processors. High-end processors find use in communications infrastructure equipment such as soft switches and firewalls, whereas usage of low-end processors lies in consumer electronics and industrial applications. Furthermore, economic betterment in Asia Pacific and consequent growth in market penetration of consumer electronics remain key contributors to regional as well as global growth.

Companies manufacturing microprocessors are investing in Research and Development (R&D) to provide new products to their customers. For instance, in March 2024, STMicroelectronics announced the launch of the STM32MP2 series, its second generation of industrial microprocessors, aimed at advancing smart factories, buildings, healthcare, and infrastructure. These MPUs will power next-generation equipment like industrial controllers, medical wearables, and smart appliances, supporting digital transformation through technologies such as cloud computing, AI, and IoT.

Request a free sample copy or view report summary: Microprocessor Market Report

Microprocessor Market Report Highlights

• Based on architecture, the ARM MPU segment is expected to register the fastest CAGR from 2024 to 2030. The segment's growth is attributed to the versatility and energy efficiency of ARM-based processors, which serve a wide range of applications.
• Based on application, the personal computers segment dominated the market in 2023. It is driven by the rising use of advanced microprocessor chips and key players like Advanced Micro Devices, Inc. introducing new products such as the Ryzen 8000G Series to enhance performance and energy efficiency.
• In 2023, Asia Pacific led the microprocessor market, driven by an improving technological infrastructure in the region. Moreover, high electronics manufacturing activity in the region drives the demand for microprocessors.
• In July 2023, Microchip Technology Incorporated opened its new R&D center in Hyderabad, India, enhancing its presence in India alongside existing centers in Bangalore and Chennai. This expansion, part of a multi-year investment initiative, aims to grow Microchip Technology Incorporated's workforce and operations in India, bolstering the company's long-term growth plans and supporting its global business needs.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-microprocessor-market

Microprocessor Market Segmentation

Grand View Research has segmented the global microprocessor market based on the architecture, application, and region:

MicroprocessorArchitecture Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2030)

• ARM MPU
  • By ARM Size
    • ARM 32-Bit
    • ARM 64-Bit
  • By End-use
    • Consumer Electronics
    • Networking & Communication
    • Automotive
    • Industrial
    • Medical Systems
    • Aerospace & Defense
    • Energy
      • Oil & Gas
      • Others
    • Others
  • x64
  • x86
  • MIPS

MicroprocessorApplication Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2030)

• Smartphones
• Personal Computers
• Servers
• Tablets
• Embedded Devices
• Others

MicroprocessorRegional Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
• Middle East and Africa (MEA)
  • Kingdom of Saudi Arabia (KSA)
  • UAE
  • South Africa

List of the Key Players in the Microprocessor Market

• Advanced Micro Devices, Inc.
• Intel Corporation
• Qualcomm Technologies, Inc.
• Texas Instruments Incorporated
• STMicroelectronics
• Microchip Technology Inc.
• NXP Semiconductors
• Renesas Electronics Corporation
• MediaTek Inc.
• NVIDIA Corporation
• Analog Devices, Inc.
• Broadcom
• Nuvoton Technology Corporation
• Samsung
• The Western Design Center, Inc.
• SiFive, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Expansion of Saturated Polyester Resin Market During 2024 – 2030 to Gain Robust Traction: Grand View Research Inc.

 Saturated Polyester Resin Market Growth & Trends

The global saturated polyester resin market size is anticipated to reach USD 7.91 billion by 2030, growing at a CAGR of 5.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising adoption of electrical vehicles (EVs) to reduce fossil fuel usage and the advent of technologies such as artificial intelligence (AI), cloud computing, edge computing and internet of things (IoT) is driving the market.

As more people and companies shift to EVs to reduce fossil fuel usage and environmental impact, the automotive industry needs high-performance materials for coatings and adhesives that offer durability, flexibility, and resistance to chemicals and weathering. Saturated polyester resins meet these needs perfectly, making them essential in the manufacturing and maintenance of EVs. Their use in protective coatings ensures the longevity and aesthetic appeal of EV components, which is crucial as the market for electric vehicles continues to expand.

Additionally, advancements in AI, cloud computing, and IoT technologies drive the production and use of sophisticated electronic devices and smart systems, which require reliable and durable materials. Saturated polyester resins are used in the coatings, adhesives, and encapsulation of electronic components, providing insulation, protection from environmental factors, and improved performance. As these technologies become more integrated into various industries, the demand for high-quality materials like saturated polyester resins continues to grow, supporting the overall market expansion.

Request a free sample copy or view report summary: Saturated Polyester Resin Market Report

Saturated Polyester Resin Market Report Highlights

• Based on material, the solid saturated polyester resins segment held the largest share, accumulating 63.1% market size in 2023. This can be attributed to the growing demand for consumer goods products.
• Based on end use, the industrial paint segment is expected to grow at the fastest CAGR over the forecast period owing to the rapid industrialization of developing economies.
• Asia Pacific dominated the market due to growing industrial, automotive, and construction industry especially in Thailand, Philippines, Bangladesh, India, Indonesia, and Vietnam.
• China was the leading manufacturer of saturated polyester resin in the Asia Pacific region and captured around 47% of the revenue market share in 2023 in this region.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-saturated-polyester-resin-market

Saturated Polyester Resin Market Segmentation

Grand View Research has segmented the global saturated polyester resin market based on material, end use, and region:

Saturated Polyester Resin Material Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2030)

• Liquid Saturated Polyester Resins
• Solid Saturated Polyester Resins

Saturated Polyester Resin End Use Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2030)

• Industrial Paints
• Powder coatings
• Coil & Can Coatings
• Automotive Paints
• Flexible Packaging
• 2k PU Coatings
• Others

Saturated Polyester Resin Regional Outlook (Revenue, USD Million; Volume, Kilotons, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK.
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

List of Key Players in the Saturated Polyester Resin Market

• DSM
• Allnex GmbH
• Arkema
• IGM Resins
• Mitsubishi Chemical Group Corporation
• Polynt S.p.A
• Hexion
• Evonik Industries AG
• BASF SE
• Ashland Global Holdings Inc.
• Sika AG
• Covestro A

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

AdTech Market Strong Application and Emerging Trends also Scope by 2030: Grand View Research Inc.

 AdTech Market Growth & Trends

The global AdTech market size is anticipated to reach USD 3,359.41 billion by 2030, growing at a CAGR of 22.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. Businesses are increasingly seeking data and analytics to understand their target audiences better and optimize their advertising spend. AdTech solutions provide tools for data collection, analysis, and targeting, enabling highly personalized and effective advertising campaigns. Programmatic advertising automates the buying and selling of ad space, eliminating the need for manual negotiations. This efficient process allows advertisers to reach a wider audience at optimized costs, while publishers can fill their ad inventory more effectively.

The pervasive nature of smartphones has fundamentally transformed the manner in which consumers access information and interact with brands. The AdTech industry strategically adapts to this paradigm shift by crafting mobile-optimized ad formats and targeting strategies, ensuring they can effectively reach consumers while they are engaged with their devices. Furthermore, the burgeoning consumption of video content coupled with the growing popularity of innovative channels such as digital out-of-home (DOOH) advertising necessitates the development of novel ad formats to captivate audience attention. AdTech companies are positioned at the forefront of this evolution, pioneering engaging formats such as interactive video advertisements and augmented reality experiences.

In response to regulations such as the General Data Protection Regulation (GDPR) and the California Consumer Privacy Act (CCPA), the AdTech industry is undergoing a necessary shift towards privacy-centric advertising practices. AdTech companies are actively developing solutions that prioritize user privacy while still delivering impactful advertising campaigns. Artificial intelligence (AI) is playing an increasingly significant role in ad targeting, personalization, and campaign optimization. By leveraging AI to analyze vast sets of data and identify user behavior patterns, AdTech companies can create more effective and targeted advertising campaigns. Connected TV (CTV) presents a unique opportunity to bridge the gap between traditional television and digital advertising. By enabling targeted advertising on smart TVs and streaming devices, CTV is poised to be a major driver of continued growth within the AdTech market.

Request a free sample copy or view report summary: AdTech Market Report

AdTech Market Report Highlights

• The global AdTech market is expected to grow at a CAGR of 22.4% from 2024 to 2030, driven by rising demand for data-driven marketing, a shift towards programmatic advertising, innovation in ad formats, and growth of mobile advertising.
• The services segment holds the biggest market share at 33.4% in 2023 and is expected to grow faster at a CAGR of 22.9% during the forecast period.
• The mobile advertising segment dominated the market with a share of 55.0% in 2023 and is projected to witness the fastest CAGR of over 23.2% during the forecast period.
• The retail & consumer goods segment dominated the market with a share of 27.2% in 2023 and is expected to expand at a CAGR of 22.1% during the forecast period.
• Regulations like GDPR and CCPA are impacting data-driven advertising methods. GDPR and CCPA restrict how businesses collect and use user data. This makes it harder for advertisers to gather detailed user profiles that were previously used for highly targeted advertising.
• The AdTech market in North America dominated the overall market in 2023 with a revenue share of 35.3%. Factors such as high digital ad spending, the presence of major AdTech companies, and robust data infrastructure propel the market growth.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-adtech-market

AdTech Market Segmentation

Grand View Research has segmented the global AdTech market based on the offering, advertising type, advertising channel, advertising format, platform, enterprise size, industry vertical, and region.

AdTech Offering Outlook (Revenue, USD Billion, 2017 - 2030)

• Solution
  • Demand-Side Platforms (DSPs)
  • Supply-Side Platforms (SSPs)
  • Ad Networks
  • Data Management Platforms (DMPs)
  • Others
• Services
  • Professional Services
    • Training & Consulting
    • Advertising Type & Integration
    • Support & Maintenance
  • Managed Services

AdTech Advertising Type Outlook (Revenue, USD Billion, 2017 - 2030)

• Programmatic Advertising
• Non-Programmatic Advertising

AdTech Advertising Channel Outlook (Revenue, USD Billion, 2017 - 2030)

• Television Advertising
• Radio Advertising
• Digital Out-of-Home (DOOH) Advertising
• Others (Mobile/Tablet Advertising)

AdTech Market Advertising Format Outlook (Revenue, USD Billion, 2017 - 2030)

• Image
• Video
• Text
• Others

AdTech Market Platform Outlook (Revenue, USD Billion, 2017 - 2030)

• Mobile
• Web
• Others

AdTech Market Enterprise Size Outlook (Revenue, USD Billion, 2017 - 2030)

• Small and Medium Enterprise (SME)
• Large Enterprise

AdTech Market Industry Vertical Outlook (Revenue, USD Billion, 2017 - 2030)

• Retail & Consumer Goods
• BFSI
• Hospitality
• Media & Entertainment
• Transport & Logistics
• Healthcare
• IT & Telecom
• Education
• Others

AdTech Market Regional Outlook (Revenue, USD Billion, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
• Middle East and Africa
  • United Arab Emirates (UAE)
  • Kingdom of Saudi Arabia (KSA)
  • South Africa

List of Key Players in the AdTech Market

• Adobe
• Alibaba Group Holding Limited
• com, Inc.
• Criteo
• Facebook Incorporation
• Google Incorporation
• Microsoft Incorporation
• SpotX
• Twitter Incorporation
• Verizon

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

UK Health Check-up Market Key Players ,Industry Share ,Growth, And Forecast To 2030: Grand View Research Inc.

 UK Health Check-up Market Growth & Trends

The UK health check-up market size is anticipated to reach USD 3.0 billion by 2030, growing at a CAGR of 6.08% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is driven by the rising prevalence of chronic diseases and the need to provide preventive screening solutions. For instance, according to UK Health indicators, the top four most prevalent chronic conditions in the UK for both men and women are allergies, hypertension, lower back disorders, and depression. Allergies emerged as the most frequently reported chronic issue among both genders, with rates of 30.4% for men and 36.0% for women. Nearly half of the UK population, comprising 45.7% of men and 50.1% of women, disclosed experiencing a persistent condition. A higher proportion of women (22.3%) indicated experiencing some activity limitations due to health issues in the past six months compared to men (18.5%).

Rising government initiatives to provide healthcare solutions is further anticipated to drive market growth. For instance, in February 2024, the National Health Service (NHS) announce the launch of a digital version of the health check-up program for citizens in England. This initiative, known as the NHS Health Check, is designed for individuals aged 40 to 74, which translates to approximately 15 million people across the country. The check-up process typically involves an appointment with a general practitioner (GP), where patients are assessed for potential risks related to type 2 diabetes, strokes, kidney disease, and certain forms of dementia.

Moreover, the introduction of telemedicine in general healthcare practices has fueled the demand for home-based testing solutions. The healthcare ecosystem's digital connectivity framework has further empowered the market during the COVID-19 pandemic. The rising incidence of life-threatening diseases is a major driver for the market. This includes the growing prevalence of non-communicable diseases, such as diabetes, hypertension, cancer, and cardiovascular diseases. This combination of the increased availability of telemedicine and home-based testing, the escalating prevalence of life-threatening diseases, and the need for early detection of asymptomatic conditions are collectively expected to drive the growth and expansion of the market. These factors have enabled individuals to manage their health proactively and have contributed to the overall development of the healthcare ecosystem during the COVID-19 pandemic and beyond.

Furthermore, the rising strategic initiatives undertaken by the key players in the market, such as enhancing healthcare services and fostering collaborations between the public and private sectors, are expected to drive the overall development and expansion of the market. Additionally, the introduction of direct-to-customer testing solutions is anticipated to contribute to the growth and accessibility of check-up services during the forecast period. For instance, in June 2023, NHS announced the launch of home-based digital health checks. This new digital health check has been introduced with the aim of delivering an additional one million checks in the first four years.

Request a free sample copy or view report summary: UK Health Check-up Market Report

UK Health Check-up Market Report Highlights

• Blood, urine, body fluid tests segment dominated the test type segment and is anticipated to grow at the fastest growth rate over the forecast period owing to the rising adoption and usage of blood, urine, and body fluid samples in preventive care diagnosis.
• Individuals dominated the end-use segment; this is attributed to the growing awareness for preventive health among the population.
• Out-of-pocket dominated the individual end-use segment owing to the rising out-of-pocket spending expenditure by customers for personal check-ups.
• Enterprise segment held a significant share in end-use segment owing to the growing number of companies providing insurance to their employees.

Access Press Release@ https://www.grandviewresearch.com/press-release/uk-health-check-up-market-analysis

UK Health Check-up Market Segmentation

Grand View Research has segmented the UK health check-up market based on test type and end-use:

UK Health Check-up Test Type Category Outlook (Revenue, USD Million; 2018 - 2030)

• Blood, Urine, Body Fluid Tests
• Imaging-Based Tests (Xray, CT, US, MRI)
• Non-imaging Tests (ECG, CPET, NCS, EMG, EEG)

UK Health Check-up End-use Outlook (Revenue, USD Million; 2018 - 2030)

• Enterprise
  • Private (Corporate) Sector
  • Government Sector
  • Insurance
• Individual
  • Out of Pocket- Direct Payment for Health Check
  • Individual Health Insurance Plan

List of Key Players in the UK Health Check-up Market

• Quest Diagnostics Incorporated
• Laboratory Corporation of America Holdings
• SYNLAB International GmbH
• OPKO Health, Inc.
• Eurofins Scientific
• UNILABS
• Sonic Healthcare Limited
• ARUP Laboratories
• Q2 Solutions

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Logistics Automation Market Is Expected To Accomplish A Valuation Of Around USD 90.0 Billion By 2030: Grand View Research Inc.

 

Logistics Automation Market Growth & Trends

The global logistics automation market size is anticipated to reach USD 90.0 billion by 2030, expanding at a CAGR of 15.0% from 2024 to 2030, according to a new report by Grand View Research, Inc. Logistics operations are critical factors in the smooth functioning of the supply chain of any business, especially low-margin, high-volume businesses. The logistics sector is witnessing a continuous increase in investments with a significant emphasis on the automation of several logistics functions. Automation enhances efficiency and aids in integrating supply chains; thus, automation is increasingly being adopted across sectors. The growing tendency of the logistics industry toward adopting automation solutions is one of the significant factors driving the growth of the logistics automation industry.

According to a DHL report published in 2018, 80% of warehouses do not have any automation support and are still operated manually, while 15% of the total warehouses are just mechanized, which means the warehouses use sorters, conveyors, picker solutions, and other machined equipment which are not necessarily automated. The report states that only 5% of total warehouses are automated. The trend displays a remarkable opportunity for the growth of the market in the coming years as companies are increasingly adopting automation in their warehouses, including autonomous robots, automated sorting systems, conveyor systems, etc. Technological developments such as communication technologies, sensors, tracking devices, computer vision, artificial intelligence, and machine learning are aiding the growth of the target market.

The e-commerce boom is resulting in increasing adoption of automation solutions owing to the enormous volumes of shipments. The e-commerce shipment volume is growing exponentially by the year, and hence the warehouses require automation solutions to meet the short delivery timelines. The e-commerce fulfillment centers are implementing automated sorting and conveyor systems and highly benefit from inventory management and order management software. Moreover, the major labor challenges faced by the logistics industry across the globe are driving the demand for logistics automation solutions.

Request a free sample copy or view report summary: Logistics Automation Market Report

Logistics Automation Market Report Highlights

• Based on components, the hardware segment dominated the market in 2023 with a share of about 66%. Autonomous robots are the largest sub-segment of hardware components in terms of revenue owing to the increasing demand for automated warehouse logistics
• Based on function, the inventory & storage management function segment is anticipated to grow at a CAGR of 16.2% during the forecast period. The inventory & storage management ensures the stocks are maintained at optimum levels, and the demand for each product determines the stock levels
• Based on logistics type, the sales logistics segment dominated the market in 2023, accounting for a market share of about 35%. Sales logistics is a critical aspect of the supply chain as it involves moving or delivering goods to the end consumer
• Based on organization size, the small and medium enterprises segment is anticipated to grow at the fastest CAGR of 16.0% during the forecast period. The growth can be attributed to the automation that helps SMEs to optimize their labor costs
• Based on software application, the order management software segment held the largest market share in 2023. The dominance of the segment is owing to the need to fulfill the orders correctly and without any delivery delays. The order management process starts when an order is placed and ends when the customer receives the order
• Based on vertical, the retail and e-commerce segment is anticipated to grow at a CAGR of 15.6%. The growth can be attributed to the increasing preference for online shopping among consumers across the globe
• The Asia Pacific segment is anticipated to register significant growth with a CAGR of 15.5%. The growth can be attributed to the increasing investments in logistics infrastructure projects in countries such as India and China
• In March 2023, Jungheinrich AG announced the acquisition of Storage Solutions, a material handling solution provider based in the U.S. Storage Solutions provides warehouse and distribution centers with solutions and services, such as lifecycle services, workflow optimization, and safety inspections. Jungheinrich AG was looking forward to leveraging the acquisition to expand its presence in the U.S.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-logistics-automation-market

Logistics Automation Market Segmentation

Grand View Research has segmented the global logistics automation market based on component, function, logistics type, organization size, software application, vertical, and region:

Logistics Automation Component Outlook (Revenue, USD Million, 2017 - 2030)

• Hardware
  • Autonomous Robots (AGV, AMR)
  • Automated Storage and Retrieval Systems (AS/RS)
  • Automated Sorting Systems
  • De-palletizing/Palletizing Systems
  • Conveyor Systems
  • Automatic Identification and Data Collection (AIDC)
• Software
  • Warehouse Management System
  • Transportation Management System
• Services
  • Consulting
  • Deployment & Integration
  • Support & Maintenance

Logistics Automation Function Outlook (Revenue, USD Million, 2017 - 2030)

• Inventory & Storage Management
• Transportation Management

Logistics Automation Logistics Type Outlook (Revenue, USD Million, 2017 - 2030)

• Sales Logistics
• Production Logistics
• Recovery Logistics
• Procurement Logistics

Logistics Automation Organization Size Outlook (Revenue, USD Million, 2017 - 2030)

• Large Enterprises
• Small & Medium Enterprises

Logistics Automation Software Application Outlook (Revenue, USD Million, 2017 - 2030)

• Inventory Management
• Order Management
• Yard Management
• Shipping Management
• Labor Management
• Vendor Management
• Customer Support
• Others

Logistics Automation Vertical Outlook (Revenue, USD Million, 2017 - 2030)

• Retail & E-commerce
• Healthcare
• Automotive
• Aerospace & Defense
• Electronics & Semiconductors
• Others

Logistics Automation Regional Outlook (Revenue, USD Million, 2017 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
• Latin America
  • Brazil
• Middle East & Africa
  • KSA
  • UAE
  • South Africa

List of Key Players in the Logistics Automation Market

• Dematic (Kion Group AG)
• Daifuku Co., Ltd.
• Swisslog Holding AG (KUKA AG)
• Honeywell International Inc.
• Murata Machinery, Ltd.
• Jungheinrich AG
• KNAPP AG
• TGW Logistics Group
• Kardex
• Mecalux, S.A.
• BEUMER GROUP
• SSI SCHÄFER AG
• Vanderlande Industries B.V.
• WITRON Logistik
• Oracle
• One Network Enterprises
• SAP

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Global Demand for Intravenous Iron Drugs Market to Incur Considerable Upsurge During 2024– 2030: Grand View Research Inc.

Intravenous Iron Drugs Market Growth & Trends

The global intravenous iron drugs market size is expected to reach USD 5.62 billion by 2030, expanding at a CAGR of 9.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Industry rivalry is expected to remain at a higher level over the forecast period. The market is dominated by global players accounting for most of the revenue share. Moreover, growing opportunities attract new players, which further augments the competitive rivalry. The market is fragmented and major players are involved in adopting extensive growth strategies such as entering strategic alliances, acquisitions, and new drug launches to capture a larger share.

The high disease burden of infectious diseases, coupled with poor nutrition, is one of the major causes of anemia among children in this region. The novel coronavirus pandemic has also increased anemia in severely affected patients, causing hypoxia in some cases. This has further increased the demand for intravenous iron drugs for the treatment of anemia across the globe.

The increase in the prevalence of anemia can also be attributed to various gynecological and gastrointestinal disorders, facilitating an increasing uptake of IV treatment globally. For instance, the overall prevalence of anemia is 29.6% in nonpregnant women and 36.5% in pregnant women of the same age group. With growing healthcare budgets and increasing investment, the market is anticipated to grow significantly during the forecast period.

Drawbacks of oral iron drugs such as digestive problems such as stomach aches, constipation, loss of appetite, nausea, and vomiting are reasons for patients to prefer intravenous drugs. The use of intravenous iron drugs has been shown to bring about increased iron adoption by the body, facilitating Erythropoiesis-stimulating Agents (ESAs) to function in an enhanced manner to improve the anemic condition. Other advantages are the preservation of heart health and the ability to be used by dialysis patients, especially those undergoing hemodialysis.

Request a free sample copy or view report summary: Intravenous Iron Drugs Market Report

Intravenous Iron Drugs Market Report Highlights

• Ferric carboxymaltose dominated the intravenous iron drugs industry in 2023 due to its increasing application, superior performance coupled with fewer adverse effects, and reduced cost
• Iron sucrose held a significant share of the market in 2023. A low rate of severe allergic reactions has increased the adoption rate of these drugs
• The chronic kidney disease segment held the largest share in 2023, due to the increasing prevalence of CKD and CKD-associated iron deficiency anemia cases
• North America held the largest regional share in 2023 due to the high demand for intravenous drugs and the increasing prevalence of GI disorders, cancer, and CKD
• Asia Pacific is estimated to exhibit the fastest growth over the forecast period attributed to growing unmet patient needs, increasing healthcare expenditure, and the local presence of established global players
• Key players include AbbVie Inc.; AMAG Pharmaceuticals (Covis Pharma); Daiichi Sankyo Company, Ltd.; Sanofi; Vifor Pharma Management Ltd. (CSL); PHARMACOSMOS A/S; Zydus Group

Access Press Release@ https://www.grandviewresearch.com/press-release/global-intravenous-iron-drugs-market

Intravenous Iron Drugs Market Segmentation

Grand View Research has segmented the global intravenous iron drugs market based on product, application,and region:

Intravenous Iron Drugs Product Outlook (Revenue, USD Million, 2018 - 2030)

• Iron Dextran
• Iron Sucrose
• Ferric Carboxymaltose
• Others

Intravenous Iron Drugs Application Outlook (Revenue, USD Million, 2018 - 2030)

• Chronic Kidney Disease
• Inflammatory Bowel Disease
• Cancer
• Other Diseases

Intravenous Iron Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

List of Key Players in Intravenous Iron Drugs Market

• AbbVie Inc.
• AMAG Pharmaceuticals (Covis Pharma)
• Daiichi Sankyo Company, Ltd.
• Sanofi
• Vifor Pharma Management Ltd. (CSL)
• PHARMACOSMOS A/S
• Zydus Group
• Rockwell Medical, Inc.

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Migraine Drugs Market to Incur Meteoric Growth During The Forecast Period: Grand View Research Inc.

Migraine Drugs Market Growth & Trends

The global migraine drugs market size is expected to be valued at USD 13.34 billion by 2030, as per a new report by Grand View Research, Inc., exhibiting an 11.9% CAGR during the forecast period. The market is largely driven by factors such as a rise in disease prevalence, development of novel therapies, lifestyle changes, and hormonal medications.

Migraine is a debilitating neurological disease characterized by recurrent attacks of severe throbbing head pain that can last for more than three days. Migraine pain may get worse on movement, preventing the patient from carrying out normal, day-to-day activities. In about one-third of attacks, both sides of the head, face, or neck are affected.

Over the past five years, the global migraine drugs market has been relatively stagnant, with the market mainly dominated by usage of generic triptans and other off-label drugs. Majority of the currently prescribed drugs for both acute and preventative treatment are associated with poor efficacy and an unfavorable side-effect profile.

Launch of Amgen/ Novartis’ CGRP mAb Aimovig and Teva Pharma’s Ajovy is the first step toward revolutionizing the treatment paradigm of migraine prevention. For drug manufacturers likely to enter the market by 2019, such as Eli Lilly, Alder BioPharma, and Biohaven Pharma, pricing will be a key differentiating factor as all CGRP-based therapies have a similar efficacy and safety profile.

Request a free sample copy or view report summary: Migraine Drugs Market Report

Migraine Drugs Market Report Highlights

• Germany leads the European market, driven by rising disease prevalence, novel drug launches, and an increase in R&D activities
• The acute migraine treatment market will be supported by the rapid uptake of novel drug classes such as CGRP receptor antagonists and ditans currently under active investigation in multiple Phase II/III trials
• Biohaven’s rimegepant is expected to face competition from Allergan's ubrogepant, which has shown superior efficacy in Phase III trials compared to rimegepant
• Eli Lilly’s Phase III 5-HT1F receptor agonist Lasmiditan is expected to be a novel first-line non triptan acute treatment option for patients in whom triptans are contradicted
• Approximately 20% of patients seeking preventive treatment for migraine do not respond to available generic medications. Several biologics and small molecules drugs are undergoing active development to target high unmet needs in the preventive treatment segment
• Drugs with novel targets in early-phase development include AOBiome Therapeutics’ AOB-203 (antibacterial), Winston Pharma’s Dolorac (histamine H1 receptor antagonists), NeuroAxons’ NXN-188 (a combination of NOS inhibitor and a triptan), and Biohaven’s BHV-3500 (gepant). These novel agents are under evaluation for both episodic and chronic migraine in multiple Phase I/II trials.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-migraine-drugs-market

Migraine Drugs Market Segmentation

Grand View Research has segmented the global migraine drugs market based on treatment, therapeutic class, route of administration, age group, availability, and region:

Migraine Drugs Treatment Outlook (Revenue, USD Million, 2018 - 2030)

• Acute
• Preventive

Migraine Drugs Therapeutic Class Outlook (Revenue, USD Million, 2018 - 2030)

• CGRP monoclonal antibodies
• CGRP small molecule antagonists
• Acetylcholine inhibitors/ neurotoxins
• Triptans
• Ditans
• Ergot alkaloids
• NSAIDs
• Others

Migraine Drugs Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Oral
• Injectable
• Others

Migraine Drugs Age Group Outlook (Revenue, USD Million, 2018 - 2030)

• Pediatric
• Adult
• Geriatric

Migraine Drugs Availability Outlook (Revenue, USD Million, 2018 - 2030)

• Prescription Drugs
• Over-the-Counter (OTC) Drugs

Migraine Drugs Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • S.
  • Canada
  • Mexico
• Europe
  • Germany
  • K.
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

List of Key Players in the Migraine Drugs Market

• AbbVie Inc.
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• GSK plc
• Eli Lilly and Company
• Pfizer Inc.
• Bausch Health Companies Inc.
• Gensco Pharma
• Impel Pharmaceuticals Inc.
• Tonix Medicines, Inc.
• Currax Pharmaceuticals LLC.
• Lundbeck

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Gene Therapy Market to Register Steadfast CAGR of 18.88% in Terms of Value from 2024 to 2030: Grand View Research Inc.

 

Gene Therapy Market Growth & Trends

The global gene therapy market is expected to reach USD 18.20 billion by 2030, registering a CAGR of 18.88% from 2024 to 2030, according to a new report by Grand View Research, Inc. The development of the market is owing to an increase in the number of gene therapy-based discoveries, increasing investment in this sector, and rising approval of gene therapy products. According to the WHO, 10 to 20 new cell and gene therapies are expected to be approved each year by 2025.

Continuous developments in recombinant DNA technology are anticipated to enhance the efficiency of gene therapy in the coming years. Hence, ongoing progresses in recombinant DNA technology are anticipated to expand the number of ongoing clinical trials for gene therapy. Primarily, these advancements are taking place in the context of various gene-editing tools and expression systems to augment the R&D for products. The advent of CRISPR/Cas9 nuclease, ZFN, and TALEN allows easy & precise genome editing. As a result, in recent times, the gene-editing space has witnessed a substantial number of research activities, which, in turn, is expected to influence the growth of the gene therapy market.

The growth of the gene therapy market is expected to be majorly benefitted from the increasing prevalence of cancer. The ongoing increase in cancer patients and related death per year emphasizes the essential for the development of robust treatment solutions. In 2020, there were around 18.1 million new cases of cancer worldwide. 9.3 million of these cases involved men, while 8.8 million involved women. Continuing developments in tumor genetic studies have delivered substantial information about cancer-related molecular signatures, which in turn, is expected to support ongoing clinical trials for cancer therapeutics.

With rising demand for robust disease treatment therapies, companies have focused their efforts to accelerate R&D for effective genetic therapies that target the cause of disease at a genomic level. . Furthermore, the U.S. FDA provides constant support for innovations in this sector via a number of policies with regard to product manufacturing. In January 2020, the agency released six final guidelines on the manufacturing and clinical development of safe and efficient products.

Furthermore, facility expansion for cell and gene therapies is one of the major factors driving the gene therapy market growth. Several in-house facilities and CDMOs for gene therapy manufacturing have begun investing to enhance their production capacity, which, in turn, is anticipated to create lucrative opportunities for market players. For instance, in April 2022, the FDA approved commercial licensure approval to Novartis for its Durham, N.C. site. This approval permits the 170,000 square-foot facility to make, test, and issue commercial Zolgensma, as well as manufacture therapy products for current & upcoming clinical trials.

Request a free sample copy or view the report summary: Gene Therapy Market Report

Gene Therapy Market Report Highlights

• The AAV segment shows a significant revenue contribution of 22% in 2023. Several biopharma companies are offering their viral vector platform for the development of AAV-based gene therapy product.
• By indication, the spinal muscular atrophy (SMA) segment dominated the market in 2023 with a share of 46.8%. Although SMA is a rare disorder, it is one of the most common fatal inherited diseases of infancy.
• The Beta-Thalassemia Major/SCD segment is anticipated to register the fastest CAGR of 38.3% over the forecast period. Gene therapy for SCD and β-thalassemia is based on transplantation of gene-modified hematopoietic stem cells.
• North America dominated the market in 2023 with the largest revenue share of 65.2% in 2023. This region is expected to become the largest routine manufacturer of gene therapy in terms of the number of approvals and revenue generated during the forecast period.
• Europe is estimated to be the fastest-growing regional segment from 2024 to 2030. This is attributed to its large population with unmet medical needs and increasing demand for novel technologies in the treatment of rare but increasingly prevalent diseases.

Access Press Release@ https://www.grandviewresearch.com/press-release/global-gene-therapy-market

Gene Therapy Market Segmentation

Grand View Research has segmented the global gene therapy market report based on indication, vector type, route of administration, and region:

Gene Therapy Indication Outlook (Revenue, USD Million, 2018 - 2030)

• Large B-Cell Lymphoma
• Multiple Myeloma
• Spinal Muscular Atrophy (SMA)
• Acute Lymphoblastic Leukemia (ALL)
• Melanoma (lesions)
• Inherited Retinal Disease
• Beta-Thalassemia Major/SCD
• Others

Gene Therapy Vector Type Outlook (Revenue, USD Million, 2018 - 2030)

• Lentivirus
• RetroVirus & gamma RetroVirus
• AAV
• Modified Herpes Simplex Virus
• Adenovirus
• Others

Gene Therapy Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)

• Intravenous
• Others

Gene Therapy Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America
  • US.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • Switzerland
• Asia Pacific
  • Japan
  • China
  • South Korea
  • Australia
• Rest of the world 

List of Key Players in the Gene Therapy Market

• Amgen Inc.
• Novartis AG
• Hoffmann-La Roche
• Gilead Sciences, Inc.
• bluebird bio, Inc.
• Bristol-Myers Squibb Company
• Legend Biotech.
• uniQure N.V.
• Merck & Co.
• Sarepta Therapeutics, Inc.
• Krystal Biotech, Inc.
• CRISPR Therapeutics

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.